Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-10 20:13:24 EDT

Explore

PostsPeople
LatestRanked
@worldphageday.bsky.socialOct 11, 2026, 12:45 AM

Calling companies & labs to spotlight their teams driving phage development. Share a short personal introduction why you became a #PhagePioneer, a proud moment from your work, a favourite team or phage image, news, and of course lots of #PhagePhun and ... WHY you love PHAGE.
#PhageSky #PhageTherapy

@dzif.bsky.socialOct 8, 2026, 7:30 AM

🦠 #INCATE, co-founded by #DZIF, awards Swiss start-up #PhalconBio €250,000 to advance preclinical development of an inhaled phage therapy for ventilator-associated pneumonia.

👉 Read more: t1p.de/0agp5

#AMR #PhageTherapy @incate.bsky.social

P@pghphageprogram.bsky.socialOct 7, 2026, 4:18 PM

Meet the Pittsburgh Phage Program (P3)!

Our new video takes you behind the scenes—from patient isolates and phage research in the lab to the physicians and patients at the center of clinical care!

#PhageTherapy #Bacteriophage #P3 #pittsburghphageprogram

@worldphageday.bsky.socialOct 2, 2026, 3:55 PM

#WorldPhageWeek 2026 - Let’s amplify the vital work of African labs, networks, and pioneers driving local solutions for global health #AngelaMakumi #MutaiIvy #PhageForum #phage_PRAN #PhageHunters #IbadanPhageTeam #PhagesforGH #WorldPhageDay #PhageTherapy #PhageAfrica #AMR #GlobalHealth #Africa

@uniofleicester.bsky.socialOct 2, 2026, 8:30 AM

News | Funding boost to tackle Salmonella in chickens with ‘bacteriophage therapy’

👉 https://le.ac.uk/news/2026/september/salmonella-bacteriophage-therapy-leicester

Researchers hope to bring a new bacteriophage product to combat Salmonella to the market

#CitizensOfChange #PhageTherapy

@epstoa.bsky.socialOct 1, 2026, 10:11 AM

Yesterday, STOA brought together leading experts & regulatory bodies to discuss the future of #PhageTherapy to combat superbugs & antimicrobial resistance #AMR💊

📺You can rewatch this #STOAevent: link.europa.eu/MHGWfF
✅Interview: sciencemediahub.eu/2026/09/23/p...

@ivarsijabs.bsky.social

© European Union 2026 - Source: EP© European Union 2026 - Source: EP© European Union 2026 - Source: EP
@razizian65.bsky.socialOct 1, 2026, 6:47 AM

🧬 Can phages + probiotics work together?

A 2025 review explores “Probiophage” for IBD.

🦠 Phages → targeted bacterial reduction
🧫 Probiotics → microbiome support

Together, they address dysbiosis and inflammation.

#PhageTherapy #Probiotics #Probiophage #Microbiome #IBD

@epstoa.bsky.socialSep 30, 2026, 7:10 AM

🔴Today at 15:00 CEST:

#STOAevent: '#PhageTherapy as a tool against antimicrobial resistance'

✅Info & watch live: https://ow.ly/JtBO50ZRmjs
✅Interview keynote speaker Dr Rācenis: https://ow.ly/n2Rt50ZRmjt

#AMR Ivars Ijabs European Medicines Agency European Centre for Disease Prevention and Control

Close-up illustration of bacteriophages attacking bacteria, highlighting phage therapy against antimicrobial resistance.
@plosbiology.orgSep 25, 2026, 4:10 PM

#PhageTherapy can fail when the immune system makes antibodies against therapeutic viruses. This study shows that fiber- and nozzle-specific antibodies block phage infection and promote aggregation-driven, Fc receptor-independent phagocytosis.
🧪 #ImmuneSky #structure #virus
buff.ly/J0FOg9g

The image shows a reconstructed model of antibody-induced phage aggregation. Phage therapy, which uses bacteria-specific viruses to treat bacterial infections, is a highly promising therapeutic strategy in the era of precision medicine. Increasing evidence suggests that antibodies generated during phage therapy can affect the efficacy of phage therapy and, in some cases, even lead to treatment failure. However, the molecular mechanisms by which phage-specific antibodies cause phage therapy failure remain to be elucidated. Using Acinetobacter baumannii and its podovirus phage AbP20 as a model, the authors revealed the antibodies targeting phage fiber and nozzle proteins induced the formation of large-sized tail-to-tail phage aggregates which possess reduced infection and facilitated susceptibility to phagocytosis, providing a new clue to understand phage-specific antibodies induced therapy failure. This image was created by Heng Xue and Hang Yang.
@plosbiology.orgSep 24, 2026, 12:10 PM

#PhageTherapy can fail when the immune system makes antibodies against therapeutic viruses. This study shows that fiber- and nozzle-specific antibodies block phage infection and promote aggregation-driven, Fc receptor-independent phagocytosis.
🧪 #ImmuneSky #structure #virus
buff.ly/J0FOg9g

The image shows a reconstructed model of antibody-induced phage aggregation. Phage therapy, which uses bacteria-specific viruses to treat bacterial infections, is a highly promising therapeutic strategy in the era of precision medicine. Increasing evidence suggests that antibodies generated during phage therapy can affect the efficacy of phage therapy and, in some cases, even lead to treatment failure. However, the molecular mechanisms by which phage-specific antibodies cause phage therapy failure remain to be elucidated. Using Acinetobacter baumannii and its podovirus phage AbP20 as a model, the authors revealed the antibodies targeting phage fiber and nozzle proteins induced the formation of large-sized tail-to-tail phage aggregates which possess reduced infection and facilitated susceptibility to phagocytosis, providing a new clue to understand phage-specific antibodies induced therapy failure. This image was created by Heng Xue and Hang Yang.
@plosbiology.orgSep 23, 2026, 8:10 AM

#PhageTherapy can fail when the immune system makes antibodies against therapeutic viruses. This study shows that fiber- and nozzle-specific antibodies block phage infection and promote aggregation-driven, Fc receptor-independent phagocytosis.
🧪 #ImmuneSky #structure #virus
buff.ly/J0FOg9g

The image shows a reconstructed model of antibody-induced phage aggregation. Phage therapy, which uses bacteria-specific viruses to treat bacterial infections, is a highly promising therapeutic strategy in the era of precision medicine. Increasing evidence suggests that antibodies generated during phage therapy can affect the efficacy of phage therapy and, in some cases, even lead to treatment failure. However, the molecular mechanisms by which phage-specific antibodies cause phage therapy failure remain to be elucidated. Using Acinetobacter baumannii and its podovirus phage AbP20 as a model, the authors revealed the antibodies targeting phage fiber and nozzle proteins induced the formation of large-sized tail-to-tail phage aggregates which possess reduced infection and facilitated susceptibility to phagocytosis, providing a new clue to understand phage-specific antibodies induced therapy failure. This image was created by Heng Xue and Hang Yang.
@infdiseasesnow.bsky.socialSep 21, 2026, 7:22 AM

[Publication] The article "Phage therapy: a national momentum gathering pace" is now available.

www.sciencedirect.com/science/arti...

#IDsky #PhageTherapy

@linq-management.bsky.socialSep 21, 2026, 7:18 AM

✨New project: #REPhRAME

REPhRAME is an EU project advancing #PhageTherapy toward clinical practice.

The aim is to find innovative solutions to recurrent urinary tract infections and to assess a new therapeutic approach in a randomised #ClinicalTrial.

➡️ www.rephrame-project.eu

@thephage.bsky.socialSep 19, 2026, 2:24 PM

Inteliphage is seeking an experienced medical officer to help shape its clinical strategy, prepare for clinical trials, collaborate with its Clinical Advisory Board, and lead discussions with regulatory authorities.

thephage.xyz/jobs/jobs/ch...

#PhageTherapy #carreer #AMR #DrugDevelopment

@proseandpassion.mastodon.social.ap.brid.gySep 18, 2026, 3:47 PM

16-Sep-2026
First-of-its-kind preventative #phageTherapy provides promising results

https://www.eurekalert.org/news-releases/1143694

#science #phages #microbiology #medicine

@virusesmdpi.bsky.socialSep 17, 2026, 8:11 AM

👉Case report in Viruses: a severely burned patient with relapsing XDR P. aeruginosa VAP & bacteremia was successfully treated with personalized nebulized + IV phage therapy, combined with IFN-γ and imipenem-relebactam.

www.mdpi.com/1999-4915/16...

#PhageTherapy #AMR

@phagelab.bsky.socialSep 16, 2026, 3:41 PM

Could we fight AMR using phages targeting resistance plamids rather than the bacteria themselves?

Our latest paper from @uniofnottingham.bsky.social, discusses how phages can select for plasmid-free, antibiotic-sensitive bacteria.

👉 www.mdpi.com/2076-0817/15...

#AMR #OneHealth #phagetherapy

@ijaa-isac.bsky.socialSep 16, 2026, 2:40 AM

🔥Check out the Hot Topic: www.sciencedirect.com/science/arti...

Growing interest in phage therapy but important knowledge gaps and barriers remain...🦠

#PhageTherapy #AMR

@isacworld.bsky.social

@virusesmdpi.bsky.socialSep 15, 2026, 10:32 AM

🌊 Review in Viruses: Marine bacteriophages may offer new tools against antimicrobial resistance through phage therapy, phage–antibiotic synergy and phage-derived enzymes.

www.mdpi.com/1999-4915/17...

#PhageTherapy #AMR

@healthcare-europe.bsky.socialSep 10, 2026, 6:39 AM

A new study led by @microberamon.bsky.social from 🇬🇧 @oxengsci.bsky.social, with @ucl.ac.uk and @uniofleicester.bsky.social, shows that #phagetherapy could help to reduce recurrent #infections, which happen when the 🦠 bacteria responsible for #UTI s ‘hide’ in the tissue of the #bladder.

Load more